More Trasylol plaintiffs sue Bayer
-Fierce Pharma
11/13/2009 - Yet another set of plaintiffs has sued Bayer over kidney damage and other injuries allegedly caused by the drug Trasylol, which used to control bleeding during heart surgery. This latest suit was filed in Wisconsin by plaintiffs from Illinois, Pennsylvania and Wisconsin. They're joining dozens of other plaintiffs who've sued Bayer over Trasylol, which was withdrawn from the market in 2007 over safety fears. More>>>

Bayer Faces Nearly 1,000 Trasylol Cases in Florida
-BNET
10/27/2009 - Bayer faces almost 1,000 lawsuits in a Florida federal district court regarding its anti-bleeding drug Trasylol, according to the docket in the case (1:08-md-01928-DMM). While there have been sporadic reports in local media of people filing claims against Bayer alleging Trasylol contributed to renal failure, there has been little overall publicity to what is clearly a massive multi-district litigation effort going on in Judge Donald Middlebrooks’ Southern District federal court. More>>>

Bayer pulls U.S. Trasylol supplies after study
-Reuters
10/19/2009 - Bayer AG is removing remaining supplies of its heart-surgery drug Trasylol from the U.S. market after a long-awaited study found it raised the risk of death compared to two alternatives, U.S. regulators said on Wednesday. More>>>

Bayer didn't warn of Trasylol's possible side effects, suit claims
-The St. Clair Record
08/31/2009 - A man and woman have filed a suit against Bayer, alleging they were not warned of possible side effects in a drug used to control bleeding in coronary artery bypass grafting. More>>>

BREAKING NEWS: Insider speech about fraud & corruption at BAYER
-LifeGen.de
05/12/2009 - It is a a major breakthrough in combating fraud and corruption: At today's annual general shareholders meeting of Germanys Bayer AG, a former pharmaceutical employee intends to unveil severe corruption practices within BAYER. More>>>

Class-action suit filed over heart drug
-CalgaryHerald
01/09/2009- A Calgary law firm has launched a class-action suit against pharmaceutical giant Bayer Inc. for its drug Trasylol, alleging it causes kidney failure, stroke and other serious health problems. More>>>

Trasylol Lawyers Take a Stance on Pharmaceutical Drug Companies
-BestSyndication
01/08/2009- For as long as large pharmaceutical drug companies have been around illegal kickbacks have been awarded to serve as an incentive for doctors to use specific drugs. These kickbacks have attributed to numerous cases where a patient has suffered due to their doctor recommending a drug that they received a kickback for. More>>>

Heart Bypass and Kidney Failure Linked to Trasylol
-Best Syndication
12/09/2008- If you recently developed kidney failure and have also undergone heart bypass surgery, the Trasylol may have been the cause. For people who were administered Trasylol during their heart bypass surgery may have caused their kidney failure. Trasylol, manufactured by Bayer Pharmaceuticals, has been linked to cause kidney complications and failure. More>>>

Lawsuit filed against Bayer over drug risks
-CTV.ca
12/08/2008- Bayer voluntarily withdrew Trasylol from the market after a clinical trial found patients treated with the drug were 53 per cent more likely to die than those treated with other anti-bleeding medications. More>>>

Trasylol Class Action Lawsuit Filed in Canada After Another Study Confirms Increased Risk of Death
-AboutLawsuits
12/04/2008- A class action lawsuit has been filed in Canada against Bayer involving their heart bypass surgery injection Trasylol. The lawsuit was filed the day after a new study was released confirming that individuals who are given the injection face an increased risk of death. More>>>

Another Study Warns of Risk From Cardiac Surgery Drug:
Patients given Trasylol have a higher death risk, data review finds
-Forbes
12/02/2008- A new study casts more doubt on the safety of the drug Trasylol (aprotinin), used to limit bleeding in patients undergoing surgery. Trasylol is already the subject of controversy in the United States, where it was removed from the market in 2007. In the new study, Canadian and Australian researchers reviewed findings from 49 randomized clinical trials. They concluded that Trasylol posed a higher risk of death for patients than other anti-bleeding drugs, called lysine analogues. More>>>

Bayer Withdraws Heart Surgery Drug from U.S. Market Following New Study Results Revealing Harm
-NaturalNews
10/09/2008- Drug maker Bayer AG has recalled all remaining stocks of the anti-bleeding medication Trasylol (aprotinin) from the U.S. market after a New England Journal of Medicine Study demonstrated that the drug increased heart surgery patients' risk of death by 53 percent. More>>>

Dialysis Lawsuit Filed in Illinois Over Heart Surgery Injection Trasylol
-AboutLawsuits.com
10/08/2008- A new lawsuit has been filed on behalf of two heart surgery patients who received an injection known as Trasylol before their operations to control bleeding. The suit seeks damages for acute renal failure requiring dialysis caused by the injection. More>>>

Act Quickly to Signs & Symptoms of Acute Kidney Failure
-Best Syndication News
09/25/2008- Have you recently experienced a lack of being able to urinate, or excessive urination, swelling, nausea, or drastic mood changes. If so you might be suffering from acute Kidney failure, in which your kidneys have suddenly lost the ability to dispose of waste. More>>>

Health Decline Sparks Open Heart Surgery Leading to Kidney Complications
-Best Syndication News
09/10/2008- In the recent decade a push for dietary health has seen a big increase in importance as the obesity rate has increased tremendously over the entire world. Whether it is because our fast pace world promotes fast eating, our society has expanded its waste line tremendously. More>>>

Triple Bypass Surgery Linked to Kidney Failure Resulting in Death
-Best Syndication News
09/04/2008- Open heart surgery is the most common surgery in the United States. This might sound alarming and might pose certain questions as to why this is occurring. The need for a bypass surgery is because there is a blockage in your arteries that is cutting off the circulation of blood. More>>>

Acute Kidney Failure Linked to Trasylol
-Best Syndication News
08/30/2008- Acute Kidney Failure, also known as renal failure, entails the abrupt loss of the use of the kidneys to excrete waste and urine. Some of the causes of acute kidney failure are infections of the kidney, obstruction of the kidney track, decreased blood flow, and other disorders that cause clotting within the kidneys blood vessels. More>>>

Heart Bypass Surgery Linked To Kidney Failure
-Best Syndication Health
08/20/2008- Heart bypass surgery is one of the most invasive surgeries to date because the chest is wide open and the heart is stopped. Common symptoms that indicate needing heart bypass surgery is severe chest pain. More>>>

Have You Been Injured by Trasylol?
-InjuryBoard.com
08/19/2008- Trasylol, a medicine manufactured by Bayer which also goes by the name aprotinin, has been widely used since the 1990s. It was used as a medicine given during heart bypass surgery to reduce bleeding and the need for blood transfusions. More>>>

A Thousand Patients Killed Each Month by Cardiac Bypass Anti-Bleeding Drug
-NaturalNews
08/14/2008- The FDA's delay in taking Trasylol off the market led to 1,000 deaths each month for a year and a half, according to the doctor who first alerted the agency to the dangers of the drug. More>>>

TRASYLOL LAWSUIT: UNDERSTAND EVERYTHING
-Best Syndication
08/07/2008- Trasylol is a drug administered to patients during surgery in order to reduce bleeding and slow down the process that is responsible for blood clots. While this drug is seemingly harmless and takes on a responsible and active role in surgery, it is reported to have caused the deaths of approximately a thousand lives per month. More>>>

Trasylol Lawyers provide Unbiased Guide
-Best Syndication
08/05/2008- Trasylol is medication that is administered by means of an injection. Its objective is to reduce bleeding during surgery by slowing down a process that causes blood clots. Although this drug provides a seemingly positive and essential attribute to surgery, there are many problems that can result from such a strong drug. More>>>

How To Avoid Acute Kidney Failure
-best syndication
08/01/2008- Acute kidney failure is a serious condition in which a loss in function is found in the kidneys that no longer allows them to remove urine and other waste without also losing electrolytes. Acute kidney failure happens very suddenly and is dangerous so it is considered a medical emergency. More>>>

Open Heart Surgery: The way to a livelier you

-BestSyndication
07/28/2008- Trasylol was a leading drug used in heart surgeries to limit the amount of blood. Such heart surgeries include open heart, single double and triple bypasses, as well as transplants. However, Trasylol was taken off the market in November of 2007 because it was linked to cause kidney failure, heart damage, strokes, and death. More>>>

The Trasylol Story Illustrates Why FDA Preemption is Bad Public Policy

-TortDeform
07/03/2008- The crux of the argument that FDA approval of a drug should preempt state lawsuits over that drug is that it should be experts at the FDA who decide whether a drug is safe and what warnings that drug’s label should carry. More>>>

Trasylol "Devastating"

-Lawyers and Settlements
06/17/2008- Because Trasylol was approved so long ago, there are many people whose loved ones were affected by the drug but do not realize it. Barbara S. says her husband, Carson, had open heart surgery in 1998, but she is only now realizing that his serious health problems may have been caused by Trasylol. More>>>

Trasylol: Pivotal Study Could Have Happened Sooner
-Lawyers and Settlements
06/08/2008- One of the lead authors of a pivotal Canadian study that most experts say will spell the end of Trasylol, has suggested that Bayer AG could have undertaken a similar study ten years ago. In that time, thousands have died. More>>>

Trasylol Recall Too Late For Many Patients

-Lawyers and Settlements
05/30/2008- Earlier this month, Bayer announced that it was recalling remaining Trasylol stocks from the US market. The move comes after repeated studies found that patients given Trasylol during open heart surgery had a higher risk of kidney failure. More>>>

End for Anti Bleeding Drug, Trasylol
-InjuryBoard
05/28/2008- In November of 2007, after initial reports were given to the Food & Drug Administration (FDA) Bayer AG, the maker of the drug Trasylol (also know as aprotinin), agreed to temporarily suspend sales and marketing of Trasylol.  More>>>

It's Game Over for Trasylol, but Bayer Refuses to Fold
-LawyersandSettlements
05/26/2008- Washington, DC: If Trasylol maker Bayer AG were into playing the odds, the Germany-based manufacturer is hedging its bets over its once-dominant anti-bleeding drug, even though most believe that the Canadian BART clinical trial has effectively sounded the death knell for a drug that has allegedly spelled death for thousands of heart patients. More>>>

Remaining Trasylol Stocks Recalled
-LawyersandSettlements

Danger From Heart Surgery Drug Confirmed
-Washington Post
05/22/2008- A new Canadian study confirms that people given Trasylol, a drug used to reduce bleeding during heart surgery, face a 53 percent increased risk of death. More>>>

BART Closes the Book on Aprotinin 
-Medscape
05/21/2008- Results of the Blood Conservation Using Antifibrinolytics in a Randomized Trial (BART), halted by the company [Bayer] last year, have now been published online May 15, 2008 in the New England Journal of Medicine, scheduled for its May 29, 2008 issue, confirming that aprotinin (Trasylol, Bayer Healthcare Pharmaceuticals), an antifibrinolytic agent designed to reduce major bleeding during coronary artery bypass graft (CABG), significantly increased the risk of death. More>>>

Study likely spells end for anti-bleeding drug

-Foster's Daily Democrat
05/19/2008- An anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs. More>>>

Bayer pulls US Trasylol supplies after study
-Reuters
05/17/2008- BOSTON, May 14 (Reuters) - Bayer AG is removing remaining supplies of its heart-surgery drug Trasylol from the U.S. market after a long-awaited study found it raised the risk of death compared to two alternatives, U.S. regulators said on Wednesday. More>>>

Bayer Will Begin Pulling Remaining Stock of Trasylol
-Bloomberg
05/16/2008- Bayer AG will begin removing the remaining stock of the drug Trasylol, used to control bleeding, from warehouses and hospitals, the U.S. Food and Drug Administration said in a statement today. More>>>

Study Confirms Trasylol Dangers
-InjuryBoard
05/16/2008- The results of a study published in the New England Journal of Medicine have confirmed preliminary findings that Bayer’s anti-bleeding medication Trasylol (aprotinin) dramatically increases a patient’s risk of death. More>>>

Trasylol Gone for Good
-NewsInferno
05/16/2008- Trasylol is being removed from the market for good. Bayer AG had suspended marketing of Trasylol, a drug used to prevent bleeding during heart surgery, in November, after a clinical trial found patients treated with Trasylol were dying at higher rates than others. More>>>

Bayer anti-bleeding drug linked to 50 per cent higher death rate than alternatives
-Orillia Packet & Times
05/16/2008- An expensive drug used to minimize severe bleeding during heart surgery actually significantly increased the risk that patients would die during surgery or in the 30 days following, a Canadian study comparing the drug to two far cheaper alternatives shows. More>>>

Is this the end of the Trasylol story?
-FiercePharma
05/15/2008 - A new study could be the last nail in Trasylol's coffin. In a head-to-head comparison of Trasylol (aprotinin) and two other anti-bleeding meds, patients getting Trasylol during heart surgery were much more likely to die than patients on the other meds. More>>>

Study likely spells end for anti-bleeding drug

-Washington Post
05/15/2008 - An anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs. More>>>

Patients given popular heart surgery drug had higher risk of dying: study

-The Ottawa Citizen
05/15/2008 - Patients who received a drug commonly used to control bleeding during heart surgery were at a higher risk of dying, new research by the Ottawa Health Research Institute reveals. More>>>

Danger From Heart Surgery Drug Confirmed

-Washington Post
05/14/2008 - A new Canadian study confirms that people given Trasylol, a drug used to reduce bleeding during heart surgery, face a 53 percent increased risk of death. More>>>

Bayer pulls Trasylol supplies after study

-Reuters
05/14/2008 - Bayer AG is removing remaining supplies of its heart-surgery drug Trasylol from the U.S. market after a long-awaited study found it raised the risk of death compared to two alternatives, U.S. regulators said on Wednesday. More>>>

Trasylol Tragedy Timeline: The Dates of Destiny

-Lawyers and Settlements
05/12/2008 - The tragedy that is Trasylol and the scores of people who have died at the hands of the expensive anti-bleeding drug reads like the plot line of a bad movie. Only in this case, the villain doesn't get it in the end. At least, not yet. That payback may eventually be found in the courts of law as hundreds of lawsuits move forward. More>>>

Trasylol: "I've Gone Through Hell"

-Lawyers and Settlements
05/09/2008 - Loretta M. says she is sure she was given Trasylol during her open heart surgeries because her doctor spoke about using blood-regulating drugs during surgery. More>>>

Trasylol: Bayer Bracing for Lawsuits

-Lawyers and Settlements
05/06/2008 - As Bayer AG continues to study the results of the Canadian BART trial on Trasylol, and whether or not those findings may compel the manufacturer to lobby health regulators as to the merits of re-marketing a now-vilified drug, its legal arm prepares for its day in court as lawsuits against Bayer mount. More>>>

Trasylol Death Unnecessary
-Lawyers and Settlements
05/04/2008- Although Trasylol has been recalled, many people are only now realizing that they or their loved ones may have been given the drug during open heart surgery and may have suffered serious adverse reactions to the drug, including kidney failure. More>>>

Trasylol May Have Caused Advanced Kidney Failure

-Lawyers and Settlements
04/29/2008 - Mark L. suffered kidney failure shortly after his open heart surgery. However, he does not know for sure if Trasylol was used. Mark is now trying to determine whether or not doctors gave him Trasylol to stop him from bleeding during surgery. More>>>

Bayer CEO says faces 78 Trasylol lawsuits in U.S.

-Reuters
04/25/2008 - Germany's Bayer AG is facing 78 lawsuits in the United States linked to its Trasylol drug used to stem bleeding during open heart surgery, its chief executive said on Friday. More>>>

Lawsuits seek damages from Bayer over anti-bleeding drug

-Miami Herald
04/23/2008 - Eight lawsuits filed in a Florida federal court are seeking damages from Bayer AG over a controversial anti-bleeding drug. More>>>

Heart Drug Trasylol Pulled From Market After 50 Percent Increase in Death Rate Discovered

-Natural News
04/20/2008 - Pharmaceutical giant Bayer AG has announced that it is withdrawing its drug Trasylol from the market in response to a request by the FDA, in the face of increasing evidence that the drug increases patients' risk of death. More>>>

Questions about Trasylol Since 1963
Lawyers and Settlements
04/20/2008- When Bayer AG convenes its annual stockholder's meeting on April 25th in Cologne, the German group Coalition against BAYER Dangers (CBG) will be on hand to introduce countermotions to the proceedings, one of which will focus on the history, and dangers of Trasylol (known as Aprotinin). More>>>

Trasylol: “What the Hell Did They Give These People?”
-Lawyers and Settlements

New Trasylol Trial Halted Due to Deaths
Lawyers and Settlements
03/29/2008-Washington, DC: On March 27, 2008 Bayer AG said that a new trial on Trasylol had to be halted because the risk of death increased due to excessive bleeding. In addition to this new trial, previous studies have shown that Trasylol has a strong link to kidney failure in patients administered the drug when undergoing heart bypass surgery. More>>>

Protect consumers' right to sue drug maker
Philadelphia Inquirer
03/14/2008 - Can you imagine what would happen if three jumbo jets crashed in one month? A thousand people dead. Uproar at the FAA. Planes grounded. Immediate comprehensive inspections of all aircraft. Congressional hearings and investigations. Everything possible would be done to immediately assure public safety. More>>>

Congress Hears Warnings about FDA
-Consumer Affairs
02/27/2008 - Congress got an earful today as it held hearings on legislation that would provide more funding and authority to the Food and Drug Administration (FDA). Consumer and industry groups said the agency is falling short in its mission to ensure the safety of drug and food products More>>>